How do pharmacists respond to complaints of acute insomnia? A simulated patient study

International Journal of Clinical Pharmacy

Volumn 33, Issue 2, 2011, Pages 237-245

  Kippist, Carly ^a   Wong, Keith ^a,b   Bartlett, Delwyn ^a,b   Saini, Bandana ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Australia; Counseling; Insomnia; Non prescription medicines; Over the counter (OTC) medicines; Simulated patient

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; CLINICAL COMPETENCE; CLINICAL DECISION MAKING; CLINICAL PHARMACY; CLINICAL PRACTICE; COMMUNITY CARE; CONTROLLED STUDY; DRUG USE; FEMALE; HEALTH PROMOTION; HUMAN; INSOMNIA; MALE; MEDICAL EDUCATION; PATIENT COUNSELING; PHARMACIST ATTITUDE; PRIORITY JOURNAL; SCORING SYSTEM; SIMULATION; SLEEP QUALITY; TOTAL QUALITY MANAGEMENT;

ACUTE DISEASE; ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; ATTITUDE OF HEALTH PERSONNEL; COMMUNITY PHARMACY SERVICES; COUNSELING; EDUCATION, PHARMACY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; NEW SOUTH WALES; NONPRESCRIPTION DRUGS; PATIENT EDUCATION AS TOPIC; PATIENT SIMULATION; PHARMACISTS; PROFESSIONAL-PATIENT RELATIONS; SELF MEDICATION; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS; YOUNG ADULT;

EID: 79958772151     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-011-9482-5     Document Type: Article

References (37)

1. Bhat A, Shafi F, Solh A. Pharmacotherapy of insomnia. Expert Opin Pharmacother. 2008;9(3):351-62. (Pubitemid 351291782)
2. Buysse DJ, Angst J, Gamma A, Ajdacic V, Eich D, Rössler W. Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep. 2008;31(4):473-80. (Pubitemid 351694269)
3. Passarella S, Duong MT. Diagnosis and treatment of insomnia. Am J Health Syst Pharm. 2008;65(10):927-34. (Pubitemid 351680041)
4. Roth T, Roehrs T, Pies R. Insomnia: pathophysiology and implications for treatment. Sleep Med Rev. 2007;11(1):71-9. (Pubitemid 46096785)
5. Sivertsen B, Krokstad S, Mykletun A, Overland S. Insomnia symptoms and use of health care services and medications: the HUNT-2 study. Behav Sleep Med. 2009;7(4):210-22.
6. Morin CM, LeBlanc M, Daley M, Grégoire JP, Mérette C. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med. 2006;7(2):123-30.
7. Taylor DJ, Lichstein KL, Durrence H, Riedel BW, Bush AJ. Epidemiology of insomnia, depression, and anxiety. Sleep. 2005; 28(11):1457-64. (Pubitemid 41572796)
8. Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry. 1996;39(6):411-8. (Pubitemid 26124560)
9. Sivertsen B, Overland S, Neckelmann D, et al. The long-term effect of insomnia on work disability: the HUNT-2 historical cohort study. Am J Epidemiol. 2006;163(11):1018-24. (Pubitemid 43987594)
10. Daley M, Morin CM, LeBlanc M, Grégoire JP, Savard J, Baillargeon L. Insomnia and its relationship to health-care utilization, work absenteeism, productivity, and accidents Sleep Med. doi: 10.1016/j.sleep.2008.04.005.
11. Bartlett DJ, Marshall NS, Williams A, Grunstein RR. Predictors of primary medical care consultation for sleep disorders. Sleep Med. 2008;9(8):857-64.
12. Bartlett DJ, Marshall NS, Williams A, Grunstein RR. Sleep health New South Wales: chronic sleep restriction and daytime sleepiness. Intern Med J. 2008;38(1):24-31.
13. Drake CL, Roehrs T, Roth T. Insomnia causes, consequences, and therapeutics: an overview. Depress Anxiety. 2003;18(4): 163-76. (Pubitemid 38056063)
14. Buysse DJ. Chronic insomnia. Am J Psychiatry. 2008;165(6): 678-86.
15. Richardson GS, Roehrs TA, Rosenthal L, Koshorek G, Roth T. Tolerance to daytime sedative effects of H1 antihistamines. J Clin Psychopharmacol. 2002;22(5):511-5.
16. Leybishkis B, Fasseas P, Ryan K. Doxylamine overdose as a potential cause of rhabdomyolysis. Am J Med Science. 2001; 322(1):48-9. (Pubitemid 32662202)
17. Thomas A, Nallur DG, Jones N, Deslandes PN. Diphenhydramine abuse and detoxification: a brief review and case report. J Psychopharmacol. 2009;23(1):101-5.
18. Benrimoj SI, Werner JB, Raffaele C, et al. A system for monitoring quality standards in the provision of non-prescription medicines from Australian community pharmacies. Pharm World Sci. 2008;30(2):147-53. (Pubitemid 351311414)
19. Black J, Saini B, Wong K. The role of pharmacists in improving the management of sleep disorders in the community. Respirology. 2007;12(1):A24.
20. Tze-Min Ang K, Saini B, Wong K. Sleep health awareness in pharmacy undergraduates and practicing community pharmacists. J Clin Pharm Ther. 2008;33:641-52.
21. Benrimoj SI, Gilbert A, Quintrell N, de Almeida Neto A. Nonprescription medicines: a process for standards development and testing in community pharmacies. Pharm World Sci. 2007;29: 386-94. (Pubitemid 47196661)
22. Schneider C, Everett W, Geelhoed E, Kendall P, Clifford R. Measuring the assessment and counseling provided with the SUPPL.y of nonprescription asthma reliever medication: a simulated patient study. Ann Pharmacother. 2009;43:1512-8.
23. Puumalainen II, Peura SH, Kansanaho HM, Benrimoj SI, Airaksinen M. Progress in patient counselling practices in Finnish community pharmacies. Int J Pharm Prac. 2005;13:149-56. (Pubitemid 40799567)
24. Berger K, Eickhoff C, Schulz M. Counselling quality in community pharmacies: implementation of the pseudo customer methodology in Germany. J Clin Pharm Ther. 2005;30:45-57. (Pubitemid 41602091)
25. Granas AG, Haugli A, Horn AM. Smoking cessation advice provided in 53 Norwegian pharmacies. Int J Pharm Pract. 2004; 12(4):179-84. (Pubitemid 39576430)
26. Sigrist T, Benrimoj SI, Hersberger K, Langford J. Changing pharmacists' and pharmacist assistants' practice in dealing with direct requests for analgesics. Int J Pharm Pract. 2002;10:23-9. (Pubitemid 34298439)
27. Chua SS, Ramachandran CD, Paraidathathu TT. Response of community pharmacists to the presentation of back pain: a simulated patient study. Int J Pharm Pract. 2006;14:171-8. (Pubitemid 44368351)
28. Watson MC, Hart J, Johnston M, et al. Exploring the SUPPL.y of non-prescription medicines from community pharmacies in Scotland. Pharm World Sci. 2008;30(5):526-35.
29. Norris PT. Purchasing restricted medicines in New Zealand pharmacies: results from a "mystery shopper" study. Pharm World Sci. 2002;24(4):149-53. (Pubitemid 34951314)
30. Pharmaceutical Society of Australia. Standards for the provision of pharmacy medicines and pharmacist only medicines in community pharmacy. Canberra: The Society, 2010.
31. Morgan M, Jenkins L, Risdale L. Patient pressure for referral for headache: a qualitative study of GPs referral behavior. Br J Gen Prac. 2007;57:29-35. (Pubitemid 46070807)
32. Charles J, Harrison C, Britt H. Insomnia. Aust Fam Physician. 2009;38(5):283.
33. Smith L, Bosnic-Anticevich S, Mitchell B, Krass I, Saini B, Armour C. Treating asthma with a self-management model of illness behavior in an Australian community pharmacy setting. Soc Sci Med. 2007;64:1501-11. (Pubitemid 46349380)
34. O'Connor J, Seeto C, Saini B, et al. Healthcare professional versus patient goal setting in intermittent allergic rhinitis. Pat Educ Couns. 2008;70:111-7. (Pubitemid 350256923)
35. Espie C, MacMahon K, Kelly H. Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavioral therapy for persistent insomnia in general practice. Sleep. 2007; 30:574-84. (Pubitemid 46941562)
36. Alte D, Weitschies W, Ritter C. Evaluation of consultation in community pharmacies with mystery shoppers. Ann Pharmacother. 2007;41:1023-30. (Pubitemid 46917630)
37. Svarstad B, Bultman D, Mount J. Patient counseling provided in community pharmacies: effects of state regulation, pharmacist age and busyness. J Am Pharm Assoc. 2004;44(1):22-5.